Examining the impact of excipient material property variation on drug product quality attributes: A quality-by-design study for a roller compacted, immediate release tablet

Journal of Pharmaceutical Sciences

Volumn 100, Issue 6, 2011, Pages 2222-2239

  Kushner, Joseph ^a   Langdon, Beth A ^a   Hiller, Jon I ^a   Carlson, Glenn T ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Excipients; Formulation; Granulation; Particle size; Solid dosage form; Tableting

Indexed keywords

EXCIPIENT; LACTOSE; MAGNESIUM STEARATE; MICROCRYSTALLINE CELLULOSE;

ARTICLE; DRUG DESIGN; DRUG QUALITY; MATERIALS TESTING; PARTICLE SIZE; TABLET FORMULATION; TABLET HARDNESS; TENSILE STRENGTH;

EID: 79954504230     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22455     Document Type: Article

References (37)

1. Food and Drug Administration. 2003. Final report on pharmaceutical cGMPs for the 21st century-a risk-based approach.
2. Yu L. 2008. Pharmaceutical quality by design: Product and process development, understanding, and control. Pharm Res 25:781-791.
3. Moreton C. 2009. Functionality and performance of excipients in a quality-by-design world part 2: Excipient variability, QbD, and robust formulations. Am Pharm Rev 12:40-45.
4. Belic A, Skrjanc I, Bozic DZ, Vrecer F. 2010. Tableting process optimization with the application of fuzzy models. Int J Pharm 389:86-93.
5. Huang J, Kaul G, Cai C, Chatlapalli R, Hernandez-Abad P, Ghosh K, Nagi A. 2009. Quality by design case study: An integrated multivariate approach to drug product and process development. Int J Pharm 382:23-32.
6. Verma S, Lan Y, Gokhale R, Burgess D. 2009. Quality by design approach to understand the process of nanosuspension preparation. Int J Pharm 377:185-198.
7. Wu H, Khan M. 2009. Quality-by-design (QbD): An integrated approach for evaluation of powder blending process kinetics and determination of powder blending end-point. J Pharm Sci 98:2784-2798.
8. Rafati H, Talebpour Z, Adlnasab L, Ebrahimi SN. 2009. Quality by design: Optimization of a liquid filled pH-responsive macroparticles using Draper-Lin composite design. J Pharm Sci 98:2401-2411.
9. Wu H, Tawakkul M, White M, Khan M. 2009. Quality-by-design: An integrated multivariate approach for the component quantification in powder blends. Int J Pharm 372:39-48.
10. Maltesen MJ, Bjerregaard S, Hovgaard L, Havelund S, van Der Weert M. 2008. Quality by design-Spray drying of insulin intended for inhalation. Eur J Pharm Biopharm 70:828-838.
11. Zidan A, Sammour O, Hammad M, Megrab NA, Habib MJ, Khan MA. 2007. Quality by design: Understanding the formulation variables of a cyclosporine A self-nanoemulsified drug delivery systems by Box-Behnken design and desirability function. Int J Pharm 332:55-63.
12. Rahman Z, Zidan AS, Habib MJ, Khan MA. 2010. Understanding the quality of protein loaded PLGA nanoparticles variability by Plackett-Burman design. Int J Pharm 389:186-194.
13. Xie L, Wu H, Shen M, Augsburger LL, Lyon RC, Khan MA, Hussain AS, Hoag SW. 2008. Quality-by-design (QbD): Effects of testing parameters and formulation variables on the segregation tendency of pharmaceutical powder measured by the ASTM D 6940-04 segregation tester. J Pharm Sci 97:4485-4497.
14. Ragan JA, Bourassa DE, Blunt J, Breen D, Busch FR, Cordi EM, Damon DB, Do N, Engtrakul A, Lynch D, McDermott RE, Mongillo JA, O'Sullivan MM, Rose PR, Vanderplas BC. 2009. Development of a practical and efficient synthesis of CP-945598-01, a CB1 antagonist for the treatment of obesity. Org Process Res Dev 13:186-197.
15. Zinchuk AV, Mullarney MP, Hancock BC. 2004. Simulation of roller compaction using a laboratory scale compaction simulator. Int J Pharm 269:403-415.
16. Landin M, Martinez-Pacheco R, Gomez-Amoza JL, Souto C, Concheiro A, Rowe RC. 1993. Influence of microcrystalline cellulose source and batch variation on the tabletting behaviour and stability of prednisone formulations. Int J Pharm 91:143-149.
17. Suzuki T, Nakagami H. 1999. Effect of crystallinity of microcrystalline cellulose on the compactability and dissolution of tablets. Eur J Pharm Biopharm 47:225-230.
18. Kothari SH, Kumar V, Banker GS. 2002. Comparative evaluations of powder and mechanical properties of low crystallinity celluloses, microcrystalline cellulose, and powdered celluloses. Int J Pharm 232:69-80.
19. Vromans H, Bolhuis GK, Lerk CF, van de Biggelaar H, Bosch H. 1987. Studies on tableting properties of lactose. VII. The effect of variations in primary particle size and percentage of amporphous lactose in spray dried lactose products. Int J Pharm 35:29-37.
20. Sebhatu T, Elamin AA, Ahlneck C. 1994. Effect of moisture sorption on tabletting characteristics of spray dried (15% amorphous) lactose. Pharm Res 11:1233-1238.
21. Rudnic EM, Kanig JL, Rhodes CT. 1985. Effect of molecular structure variation on the disintegrant action of sodium starch glycolate. J Pharm Sci 74:647-650.
22. Bolhius GK, van Kamp HV, Lerk CF. 1986. On the similarity of sodium starch glycolate form different sources. Drug Dev Ind Pharm 12:621-630.
23. Bolhuis GK, Arends-Scholte AW, de Stuut GJ. 1994. Disintegration efficiency of sodium starch glycolates, prepared from different native starches. Eur J Pharm Biopharm 40:317-320.
24. Dansereau R, Peck GE. 1987. The effect of the variability in the physical and chemical properties of magnesium stearate on the properties of compressed tablets. Drug Dev Ind Pharm 13:975-999.
25. Leinonen UI, Jalonen HU, Vihervaara PA, Laine ESU. 1992. Physical and lubrication properties of magnesium stearate. J Pharm Sci 81:1194-1198.
26. Barra J, Somma R. 1996. Influence of the physicochemical variability of magnesium stearate on its lubricant properties: Possible solutions. Drug Dev Ind Pharm 22:1105-1120.
27. Rao KP, Chawla G, Kaushal AM, Bansal AK. 2005. Impact of solid-state properties on lubrication efficacy of magnesium stearate. Pharm Dev Tech 10:423-437.
28. Hlinak AJ, Kuriyan K, Morris KR, Reklaitis GV, Basu PK. 2006. Understanding critical material properties for solid dosage form design. J Pharm Innov 1:13-17.
29. Okoye P, Wu SH. 2007. Lubrication of direct-compressible blends with magnesium stearate monohydrate and dihydrate. Pharm Technol 31:116-129.
30. Guerin E, Tchoreloff P, Leclerc B, Tanguy D, Deleuil M, Couarraze G. 1999. Rheological characterization of pharmaceutical powders using tap testing, shear cell and mercury porosimeter. Int J Pharm 189:91-103.
31. Podczeck F, Newton JM. 2000. Powder and capsule filling properties of lubricated granulated cellulose powder. Eur J Pharm Biopharm 50:373-377.
32. Zhou Q, Armstrong B, Larson I, Stewart PJ, Morton DAV. 2010. Improving powder flow properties of a cohesive lactose monohydrate powder by intensive mechanical dry coating. J Pharm Sci 99:969-981.
33. Pingali KC, Saranteas K, Foroughi R, Muzzio FJ. 2009. Practical methods for improving flow properties of active pharmaceutical ingredients. Drug Dev Ind Pharm 35:1460-1469.
34. US Pharmacopeia XXXII. 2008. General chapter 1216. Rockville, Maryland: US Pharmacopeial Convention, pp 725.
35. Almaya A, Aburub A. 2008. Effect of particle size on compaction of materials with different deformation mechanisms with and without lubricants. AAPS PharmSciTech 9:414-418.
36. Sun C, Himmelspach MW. 2006. Reduced tabletability of roller compacted granules as a result of granule size enlargement. J Pharm Sci 95:200-206.
37. Desai RP, Neau SH, Pather SI, Johnston TP. 2001. Fine-particle ethylcellulose as a tablet binder in direct compression, immediate-release tablets. Drug Dev Ind Pharm 27:633-641.